Free Trial

Docusign (NASDAQ:DOCU) CEO Allan Thygesen Sells 40,000 Shares

Docusign logo with Computer and Technology background

Key Points

  • Docusign CEO Allan Thygesen sold 40,000 shares at an average price of $69.69, totaling approximately $2.79 million, reducing his stake by 22.70%.
  • The company reported $800.64 million in revenue for the last quarter, surpassing expectations, with a 9.08% net margin and 14.01% return on equity.
  • Docusign's Board has approved a $1 billion share buyback plan, indicating confidence in the company’s current valuation amid its stock trading between a 52-week low of $61.91 and high of $107.86.
  • Interested in Docusign? Here are five stocks we like better.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) CEO Allan Thygesen sold 40,000 shares of the company's stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $69.69, for a total transaction of $2,787,600.00. Following the completion of the transaction, the chief executive officer owned 136,246 shares in the company, valued at approximately $9,494,983.74. This trade represents a 22.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Docusign Stock Performance

DOCU traded down $0.87 on Thursday, reaching $68.10. The company had a trading volume of 4,797,959 shares, compared to its average volume of 2,766,788. Docusign Inc. has a fifty-two week low of $61.91 and a fifty-two week high of $107.86. The stock has a market cap of $13.69 billion, a P/E ratio of 51.20, a P/E/G ratio of 3.58 and a beta of 1.02. The company's fifty day moving average is $76.62 and its 200 day moving average is $79.30.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The business had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. During the same quarter in the prior year, the business earned $0.97 EPS. Docusign's quarterly revenue was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, sell-side analysts expect that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its Board of Directors has approved a share buyback plan on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 6.6% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on DOCU shares. Citigroup boosted their price objective on shares of Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, September 4th. Royal Bank Of Canada boosted their price objective on shares of Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a report on Friday, September 5th. Needham & Company LLC reissued a "hold" rating on shares of Docusign in a report on Friday, September 5th. Wells Fargo & Company boosted their price objective on shares of Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a report on Friday, September 5th. Finally, Morgan Stanley boosted their price objective on shares of Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a report on Monday, September 8th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $94.14.

Read Our Latest Report on DOCU

Institutional Trading of Docusign

Institutional investors and hedge funds have recently made changes to their positions in the company. Hemington Wealth Management lifted its holdings in shares of Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock worth $28,000 after acquiring an additional 264 shares during the period. Banque Transatlantique SA acquired a new position in Docusign during the 1st quarter worth approximately $26,000. Golden State Wealth Management LLC increased its position in Docusign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after purchasing an additional 322 shares in the last quarter. Summit Securities Group LLC acquired a new position in Docusign during the 1st quarter worth approximately $34,000. Finally, MassMutual Private Wealth & Trust FSB increased its position in Docusign by 153.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock worth $37,000 after purchasing an additional 274 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Docusign Company Profile

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Recommended Stories

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.